S. Yoo

发表

A comparative molecular field analysis and molecular modelling studies on pyridylimidazole type of angiotensin II antagonists.

K. Yi, S. Lee, S. Yoo, 1999, Bioorganic & medicinal chemistry.

KR-31543 reduces the production of proinflammatory molecules in human endothelial cells and monocytes and attenuates atherosclerosis in mouse model

G. Oh, J. Yoo, S. Yoo, 2012, Experimental & Molecular Medicine.

Shared determinants of receptor binding for subtype selective, and dual endothelin‐angiotensin antagonists on the AT1 angiotensin II receptor

K. Sandberg, S. Yoo, D. Dascal, 1998, FEBS letters.

Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones.

P. Arvan, H. Targovnik, G. Medeiros-Neto, 1996, The Journal of clinical investigation.

The conformation and activity relationship of benzofuran type of angiotensin II receptor antagonists.

S. Kim, S. Yoo, D. Lee, 2000, Bioorganic & medicinal chemistry.

Development of a time-resolved fluorometric assay for the high throughput screening of melanin concentrating hormone receptor antagonists.

Gun-Do Kim, S. Yoo, Sunghou Lee, 2006, Journal of pharmacological and toxicological methods.

Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980.

N. Kang, E. Hwang, S. Yoo, 2009, Biochemical pharmacology.

KR-31761, a novel K+(ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K+(ATP) and Sarcolemmal K+(ATP) channels in rat models of ischemia/reperfusion-induced heart injury.

K. Yi, H. Won, H. Seo, 2009, Journal of pharmacological sciences.

Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitors.

Min Goo Lee, K. Yi, Yi-Sook Jung, 2007, European journal of pharmacology.

KR-31378 protects cardiac H9c2 cells from chemical hypoxia-induced cell death via inhibition of JNK/p38 MAPK activation.

K. Yi, Yong-Sam Jung, Eunhee Kim, 2004, The Japanese journal of physiology.

KR-31378, a novel benzopyran analog, attenuates hypoxia-induced cell death via mitochondrial KATP channel and protein kinase C-epsilon in heart-derived H9c2 cells.

K. Yi, Yi-Sook Jung, M. J. Kim, 2004, European journal of pharmacology.

Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues.

K. Yi, H. Seo, J. Suh, 2003, European journal of medicinal chemistry.

KR-31466, a benzopyranylindol analog, attenuates hypoxic injury through mitochondrial K(ATP) channel and protein kinase C activation in heart-derived H9c2 cells.

K. Yi, Yi-Sook Jung, E. Baik, 2003, Journal of pharmacological sciences.

Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.

Jae-Gook Shin, Woo-Young Kim, S. Yoo, 2019, Drug metabolism and pharmacokinetics.

The conformation and activity relationship of fused analogs of DuP753.

S. Lee, S. Yoo, N. Kim, 1995, Bioorganic & medicinal chemistry.

Total synthesis of erythromycins. 5. Total synthesis of erythronolide A [41]

E. Corey, K. Nambiar, J. Falck, 1979 .

Identification of a novel antiangiogenic agent; 4-(N-imidazol-2-ylmethyl)amino benzopyran analogues.

K. Yi, Guncheol Kim, Chong-Ock Lee, 2003, Bioorganic & medicinal chemistry letters.

Intracellular protein transport to the thyrocyte plasma membrane: potential implications for thyroid physiology.

P. Arvan, D. Prabakaran, S. Yoo, 1997, Thyroid : official journal of the American Thyroid Association.

Determination of a dipeptidyl peptidase IV agonist, β-aminoacyl containing thiazolidine derivatives (KR-66223) in rat plasma by liquid chromatography-tandem mass spectrometry.

S. Schneider, I. Song, S. Yoo, 2011, Journal of pharmaceutical and biomedical analysis.

KR-31372 inhibits KDR/Flk-1 tyrosine phosphorylation via K+(ATP) channel opening in its antiangiogenic effect.

K. Hong, Ki Young Kim, S. Yoo, 2003, European journal of pharmacology.

Effects of sabiporide, a specific Na+/H+ exchanger inhibitor, on neuronal cell death and brain ischemia

K. Yi, B. Lee, Yi-Sook Jung, 2005, Brain Research.

Cardioprotective effects of the novel Na+/H+ exchanger-1 inhibitor KR-32560 in a perfused rat heart model of global ischemia and reperfusion: Involvement of the Akt-GSK-3β cell survival pathway and antioxidant enzyme

K. Yi, S. Yoo, W. Choi, 2010, Archives of pharmacal research.

Pharmacological profile of KR-33028, a highly selective inhibitor of Na+/H+ exchanger.

K. Yi, Yi-Sook Jung, M. J. Kim, 2006, European journal of pharmacology.

KR-32570, a novel Na+/H+ exchanger-1 inhibitor, attenuates hypoxia-induced cell death through inhibition of intracellular Ca2+ overload and mitochondrial death pathway in H9c2 cells.

K. Yi, Yi-Sook Jung, M. J. Kim, 2005, European journal of pharmacology.

TM‐25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co‐activator TAZ

S. Yoo, E. Jang, M. Bae, 2012, British journal of pharmacology.

KR 31372, a benzopyran derivative, inhibits oxidized LDL‐stimulated proliferation and migration of vascular smooth muscle cells

K. Hong, H. Ha, S. Yoo, 2000, Fundamental & clinical pharmacology.

SKP-450 inhibits migration and DNA synthesis stimulated by oxidized low density lipoprotein in smooth muscle cells.

W. S. Lee, K. Hong, B. Rhim, 1999, European journal of pharmacology.

Effects of SK-1080 on Intimal Thickening and Impaired Vascular Relaxation after Ballon Injury in Rats

B. Lee, S. Yoo, Hwa-Sup Shin, 2002, Pharmacology.

Pharmacological Characterization of KR‐30988, a Novel Non‐peptide AT1 Receptor Antagonist, in Rat, Rabbit and Dog

Y. Jung, Yi-Sook Jung, H. Seo, 1999, The Journal of pharmacy and pharmacology.

Effects of KR-30035, a novel multidrug-resistance modulator, on the cardiovascular system of rats in vivo and on the cell cycle of human cancer cells in vitro

K. Yi, B. Lee, S. Yoo, 2000, Anti-cancer drugs.

Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.

K. Hong, B. Rhim, S. Yoo, 1994, The Journal of pharmacology and experimental therapeutics.

Expression of the human β3 integrin subunit in mouse smooth muscle cells enhances IGF‐I‐stimulated signaling and proliferation

L. Maile, D. Clemmons, S. Yoo, 2008, Journal of cellular physiology.

Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/A

J. H. Lee, K. Hong, Ki Young Kim, 2004, European journal of pharmacology.

Bayesian Model for the Classification of GPCR Agonists and Antagonists

K. No, Ky-Youb Nam, Inhee Choi, 2010 .

Prevention of lipopolysaccharide-induced apoptosis by (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine, a benzopyran analog, in endothelial cells.

K. Hong, Ki Young Kim, S. Chae, 2002, The Journal of pharmacology and experimental therapeutics.

Prevention of Lipopolysaccharide-Induced Apoptosis by (2 S ,3 S ,4 R )- N (cid:1) -Cyano- N -(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2 H -benzopyran-4-yl)- N (cid:2) benzylguanidine, a Benzopyran Analog, in Endothelial Cells

K. Hong, Ki Young Kim, S. Chae, 2002 .

Biochemical basis for a cholesterol-lowering activity of 2-[2"-(1",3"-dioxolane)]-2-methyl-4-(2'-oxo-1'-pyrrolidinyl)-6- nitro-2H-1-benzopyran (SKP-450), a novel antihypertensive agent.

Y. Paik, S. Yoo, D. Lim, 1999, Biochemical pharmacology.

Combined angiotensin converting enzyme inhibition and angiotensin AT 1 receptor blockade up-regulates myocardial AT receptors in remodeled

C. Kramer, K. Sandberg, S. Yoo, 2001 .

Identification of 4-[4-(4-Fluoro-Phenyl)-Thiazol-2-Ylamino]-2,6-Dimethyl-Phenol (KR-33749) as an Inhibitor of 5-Lipoxygenase with Potent Antiinflammatory Activity

C. Kim, H. Cheon, N. Kang, 2010, Pharmacology.

Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice

E. Hwang, S. Yoo, Hee Yeon Won, 2011, PloS one.

Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity

K. Yi, Chong-Ock Lee, B. Lee, 2003, Anti-cancer drugs.

Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.

Y. Jung, S. Yoo, H. Shin, 1999, Journal of cardiovascular pharmacology.

Antiangiogenic Effect of KR-31372 by Apoptosis via Mediation of Mitochondrial KATP Channel Opening and the Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation

K. Hong, Ki Young Kim, S. Yoo, 2003, Journal of Pharmacology and Experimental Therapeutics.

Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts.

Y. Jung, C. Moon, S. Yoo, 1998, Japanese Journal of Pharmacology.

A novel radioligand for imaging the AT1 angiotensin receptor with PET.

Z. Szabo, R. Dannals, H. Ravert, 2004, Nuclear medicine and biology.

KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury

K. Yi, H. Won, H. Seo, 2008, Archives of pharmacal research.

Cardioprotective effects of bms-180448, a prototype mitokatp channel opener, and the role of salvage kinases, in the rat model of global ischemia and reperfusion heart injury

K. Yi, Ju-Han Lee, Bokyung Kim, 2007, Archives of pharmacal research.

Differential action of KR‐31378, a novel potassium channel activator, on cardioprotective and hemodynamic effects

H. Seo, B. Lee, S. Yoo, 2001 .

Cardioprotective Effects of [5-(2-Methyl-5-Fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32568) in an Anesthetized Rat Model of Ischemia and Reperfusion Heart Injury

K. Yi, Y. Yun, S. Yoo, 2005, Pharmacology.

Cardioprotective Effects of (2S,3R,4S)-N’-Benzyl-N’’-Cyano-N-(3,4-Dihydro-2-Dimethoxymethyl-3-Hydroxy-2-Methyl-6-Nitro-2H-Benzopyran-4-yl)-Guanidine (KR-31372) in Rats and Dogs

H. Seo, B. Lee, S. Yoo, 2004, Pharmacology.

KR-33028, a Novel Na + /H + Exchanger-1 Inhibitor, Attenuates Glutamate-Induced Apoptotic Cell Death through Maintaining Mitochondrial Function

K. Yi, B. Lee, Yi-Sook Jung, 2011 .

Predictive models of Cannabinoid-1 receptor antagonists derived from diverse classes.

N. Kang, S. Yoo, Gil Nam Lee, 2009, Bioorganic & medicinal chemistry letters.

Posttranscriptional mechanisms contribute to osmotic regulation of ANG type 1 receptors in cultured rat renomedullary interstitial cells.

K. Sandberg, C. Maric, S. Yoo, 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

KR-31378 protects neurons from ischemia-reperfusion brain injury by attenuating lipid peroxidation and glutathione loss.

I. Cho, S. Yoo, Sun‐Ok Kim, 2004, European journal of pharmacology.

Novel Inhibitors of Prolyl 4-Hydroxylase; Solid-phase Synthesis of 2,2-Dimethyl-3,4-Dialkoxy-Substituted 6-Aminobenzopyran Derivatives

M. Dong, Young-Baik Cho, Jin-soo Seo, 2006 .

BMS-191095, a cardioselective mitochondrial katp opener, inhibits human platelet aggregation by opening mitochondrial katp channels

K. Yi, Y. Yun, S. Yoo, 2005, Archives of pharmacal research.

Effects of [5-(2-methoxy-5-fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32560), a novel sodium/hydrogen exchanger-1 inhibitor, on myocardial infarct size and ventricular arrhythmias in a rat model of ischemia/reperfusion heart injury.

K. Yi, Y. Yun, S. Yoo, 2005, Journal of pharmacological sciences.

Hemodynamic profile of SKP-450, a new potassium-channel activator.

S. Yoo, H. Shin, B. Lee, 1998, Journal of cardiovascular pharmacology.

Design, syntheses and biological evaluations of nonpeptidic caspase 3 inhibitors

K. Yi, Yong-Sam Jung, Sunkyung Lee, 2002 .

(2-Aryl-5-methylimidazol-4-ylcarbonyl)guanidines and (2-aryl-5-methyloxazol-4-ylcarbonyl)guanidines as NHE-1 inhibitors.

K. Yi, Sunkyung Lee, B. Lee, 2009, Bioorganic & medicinal chemistry letters.

The effect of Na+/H+ exchanger-1 inhibition by sabiporide on blood–brain barrier dysfunction after ischemia/hypoxia in vivo and in vitro

Yi-Sook Jung, Sung Lyea Park, S. Yoo, 2010, Brain Research.

Coordinate regulation of canine glomeruli and adrenal angiotensin receptors by dietary sodium manipulation.

Z. Szabo, K. Sandberg, H. Ji, 2001, Kidney international.

Discovery of non-LBD inhibitor for androgen receptor by structure-guide design.

N. Kang, Nakjeong Kim, S. Yoo, 2013, Bioorganic & medicinal chemistry letters.

Pharmacological characterization of vasorelaxant effects of BMS-180448, a novel cardioselective ATP-sensitive potassium channel opener, in rat aorta.

Y. Yun, Yong-ri Jin, S. Yoo, 2003, Journal of pharmacological sciences.

In vitro pharmacology of DuP 753.

P. Timmermans, W. Price, J. Duncia, 1991, American journal of hypertension.

Quantitative determination of enzalutamide, an anti-prostate cancer drug, in rat plasma using liquid chromatography-tandem mass spectrometry, and its application to a pharmacokinetic study.

N. Kang, Ji-Hye Song, Nakjeong Kim, 2014, Biomedical chromatography : BMC.

Reactivity of peptide hydroxamates: A model for the biosynthesis of β-lactam antibiotics

A. Scott, S. Yoo, Sung-Kee Chung, 1976 .

Ligand-regulated secretion of recombinant annexin V from cultured thyroid epithelial cells.

M. Kaetzel, J. Dedman, S. Yoo, 2002, American journal of physiology. Cell physiology.

A new efficient synthesis of Ro-31-6930, a potent potassium channel activator, and its analogs

J. Suh, S. Yoo, Nakcheol Jeong, 1992 .

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

P. Timmermans, W. Price, J. Duncia, 1990, The Journal of pharmacology and experimental therapeutics.

The conformation and activity relationship of benzofuran derivatives as angiotensin II receptor antagonists.

S. Kim, S. Yoo, S. Lee, 1997, Bioorganic & medicinal chemistry.

Reduction of Organic Compounds with Sodium Borohydride-Copper(II) Sulfate System

S. Yoo, Sang-hee Lee, 1990 .

Total Synthesis of Erythromycins. 4. Total Synthesis of Erythronolide B1

E. Corey, K. Nicolaou, J. Falck, 1978 .

TOTAL SYNTHESIS OF ERYTHROMYCINS. 5. TOTAL SYNTHESIS OF ERYTHRONOLIDE A

E. Corey, K. Nambiar, J. Falck, 1980 .

A Dramatic Acceleration of the Pauson-Khand Reaction by Trimethylamine N-Oxide1,2

S. H. Lee, Y. Chung, S. Yoo, 1991 .

Solid-phase synthesis of 5-amino-1-(substituted thiocarbamoyl)pyrazole and 1,2,4-triazole derivatives via dithiocarbazate linker.

S. Yoo, Y. Gong, D. Lee, 2005, Journal of combinatorial chemistry.

3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors.

K. Yi, Sunkyung Lee, B. Lee, 2007, Bioorganic & medicinal chemistry letters.

Synthesis of 5‐Aryl and Vinyl Tetrazoles by the Palladium‐Catalyzed Cross‐Coupling Reaction.

K. Yi, S. Yoo, 1995 .

Construction of 6-amino-2,2-dimethyl-3,4,6-trisubstituted-2H-1-benzopyran library by solid phase synthesis.

Ji Yeon Park, Jin-soo Seo, S. Yoo, 2003, Journal of combinatorial chemistry.

Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.

E. J. Kim, S. Yoo, Myung G. Lee, 2003, Journal of pharmaceutical sciences.

A Total Synthesis of (-)-.alpha.-Kainic Acid Involving a Pauson-Khand Reaction as the Key Step

S. H. Lee, S. Yoo, 1994 .

Synthesis and biological evaluation of 3-substituted-benzofuran-2-carboxylic esters as a novel class of ischemic cell death inhibitors.

K. Yi, Yun S. Lee, Eunhee Kim, 2010, Bioorganic & medicinal chemistry letters.

Oxidative debenzylation of 4-methoxy-α-methylbenzyl esters

S. Yoo, Ryung Kim Hye, Yong Kyu, 1990 .

TOTAL SYNTHESIS OF ERYTHROMYCINS. 4. TOTAL SYNTHESIS OF ERYTHRONOLIDE B

E. Corey, K. Nicolaou, J. Falck, 1978 .

Solid phase synthesis of biphenyltetrazole derivatives

K. Yi, Jin-soo Seo, S. Yoo, 1997 .

The reaction of tetrazolylimines with Grignard reagents

S. Yoo, Y. Gong, 1997 .

Synthesis of 5-aryl and vinyl tetrazoles by the palladium-catalyzed cross-coupling reaction

K. Yi, S. Yoo, 1995 .

Daxx is a key downstream component of receptor interacting protein kinase 3 mediating retinal ischemic cell death

Yun S. Lee, Eunhee Kim, S. Yoo, 2013, FEBS letters.

Introduction of Heterocycles at the 2-Position of Indoline as Ester Bioisosteres

K. Yi, Sunkyung Lee, S. Yoo, 2004 .

Cardiovascular Pharmacology of SKP-450, a New Potassium Channel Activator, and Its Major Metabolites SKP-818 and SKP-310

H. Seo, B. Lee, S. Yoo, 1998, Pharmacology.

Anti-ulcer activity of SKP-450, a novel potassium channel activator, in rats.

H. Cheon, S. Yoo, H. Kim, 1999, Pharmacological research.

FUROXANS AS POTENTIAL NITRIC OXIDE GENERATOR : MECHANISTIC SPECULATION ON THE ELECTRON IMPACTED FRAGMENTATION

K. Hwang, S. Yoo, Y. Shin, 1995 .

(5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1.

K. Yi, Sunkyung Lee, B. Lee, 2005, Journal of medicinal chemistry.

Neuroprotective effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378), a benzopyran analog, against focal ischemic brain damage in rats.

H. Shin, J. H. Lee, K. Hong, 2002, The Journal of pharmacology and experimental therapeutics.

KR‐31378 ameliorates atherosclerosis by blocking monocyte recruitment in hypercholestrolemic mice

Hyoung‐Chin Kim, S. Yoo, Jae-Hoon Choi, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

X-ray Photoelectron Spectroscopy Analysis of Solid-Phase Reactions Using 3-Brominated Wang Resin

M. Sung, Jin-soo Seo, S. Yoo, 1999 .

An efficient synthesis of the basic pyrrolidine ring for the kainoids

Nakjeong Kim, S. Yoo, Sang-hee Lee, 1988 .

Docking-based 3D-QSAR study for selectivity of DPP4, DPP8, and DPP9 inhibitors.

Chong Hak Chae, Sung-Eun Yoo, Nam Sook Kang, 2007, Bioorganic & medicinal chemistry letters.

Costunolide, a sesquiterpene from the stem bark of Magnolia sieboldii, inhibits the RAS-farnesyl-proteintransferase.

S. Ryu, Y. K. Kim, S. Yoo, 2001, Planta Medica.

Epimerization in Intramolecular Carbanilide Cyclization to Hydantoins: A Computational Study.

S. Yoo, Soo-Kyung Kim, M. Kurth, 2002 .

Neurorestorative Effects of a Novel Fas-Associated Factor 1 Inhibitor in the MPTP Model: An [18F]FE-PE2I Positron Emission Tomography Analysis Study

Sang Eun Kim, Eunhee Kim, S. Yoo, 2020, Frontiers in Pharmacology.

In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes

K. Yi, Kwang-Hyeon Liu, Hyunmi Kim, 2005, Archives of pharmacal research.

Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.

K. Yi, Nakjeong Kim, B. Lee, 2011, Bioorganic & medicinal chemistry letters.

A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases.

P. Arvan, S. Yoo, P. Kim, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Combined angiotensin converting enzyme inhibition and angiotensin AT(1) receptor blockade up-regulates myocardial AT(2) receptors in remodeled myocardium post-infarction.

C. Kramer, K. Sandberg, S. Yoo, 2001, Cardiovascular research.

Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation.

E. Hwang, S. Yoo, Hee Yeon Won, 2010, Biochemical pharmacology.

Protective effect of KR-31378 on oxidative stress in cardiac myocytes

K. Yi, Yi-Sook Jung, E. Baik, 2005, Archives of pharmacal research.

Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Potassium Channel Opener, SKP‐450, in Healthy Volunteers

Joo-Youn Cho, K. Yu, S. Yi, 2000, Journal of clinical pharmacology.

Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration.

Y. Kong, K. Kwon, Y. Lee, 2013, Human molecular genetics.

Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles.

J. Y. Lee, K. Hong, B. Rhim, 1996, The American journal of physiology.

Novel colchicine derivatives enhance graft survival after transplantation via suppression of T‐cell differentiation and activity

Y. Wee, Y. Kim, M. Choi, 2019, Journal of cellular biochemistry.

A novel anti-ischemic ATP-sensitive potassium channel (K(ATP)) opener without vasorelaxation: N-(6-aminobenzopyranyl)-N'-benzyl-N' '-cyanoguanidine analogue.

K. Yi, H. Seo, H. S. Shin, 2001, Journal of medicinal chemistry.

PET Imaging of the AT1 receptor with [11C]KR31173.

Z. Szabo, R. Dannals, J. Hilton, 2006, Nuclear medicine and biology.

Discovery of new inhibitor for PDE3 by virtual screening.

Ki Young Kim, N. Kang, S. Yoo, 2011, Bioorganic & medicinal chemistry letters.

Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.

K. Yi, Sunkyung Lee, B. Lee, 2005, European journal of pharmacology.

Novel Receptor Surface Approach for 3D-QSAR: The Weighted Probe Interaction Energy Method

Chong Hak Chae, Whanchul Shin, Sung-Eun Yoo, 2004, J. Chem. Inf. Model..

Oxidoreductase Interactions Include a Role for ERp72 Engagement with Mutant Thyroglobulin from the rdw/rdw Rat Dwarf*

P. Arvan, W. Abplanalp, T. Agui, 2007, Journal of Biological Chemistry.

KR-31831, benzopyran derivative, inhibits VEGF-induced angiogenesis of HUVECs through suppressing KDR expression.

Hyun Seok Song, K. Yi, S. Yoo, 1992, International journal of oncology.

KR-30450, a newly synthesized benzopyran derivative, activates the cardiac ATP-sensitive K+ channel.

S. Chae, D. Kim, Y. Kwak, 1995, The Journal of pharmacology and experimental therapeutics.

Fas‐associated factor 1 induces the accumulation of α‐synuclein through autophagic suppression in dopaminergic neurons

Eunhee Kim, S. Yoo, Bok-seok Kim, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors.

Jie-Oh Lee, Sung Soo Kim, S. Schneider, 2011, Bioorganic & medicinal chemistry letters.

Effects of KR‐33028, a novel Na+/H+ exchanger‐1 inhibitor, on ischemia and reperfusion‐induced myocardial infarction in rats and dogs

K. Yi, H. Seo, Sunkyung Lee, 2007, Fundamental & clinical pharmacology.

Effects of KR-33028, a novel Na+/H+ exchanger-1 inhibitor, on glutamate-induced neuronal cell death and ischemia-induced cerebral infarct

Min Goo Lee, K. Yi, B. Lee, 2009, Brain Research.

4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors.

K. Yi, Sunkyung Lee, B. Lee, 2005, Bioorganic & medicinal chemistry letters.

Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.

Kwang-Hyeon Liu, Hyunmi Kim, H. Cheon, 2006, Toxicology Letters.

Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart.

K. Yi, H. Seo, Sunkyung Lee, 2005, European journal of pharmacology.

Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action

K. Yi, Y. Yun, Yong-ri Jin, 2006, Archives of pharmacal research.

Prediction of LUMO energy and rate constant by comparative molecular field analysis (CoMFA)

SUNG-EUN YOO, OK JA CHA, S. Yoo, 1995, J. Comput. Chem..

Effects of a new neuroprotective agent KR-31378 on liver cytochrome P450s in male sprague dawley rats

Ji-Young Kim, T. Jeong, S. Yoo, 2003, Archives of pharmacal research.

Synthesis and photochromic properties of phenanthropyran derivative substituted with styryl group

K. Yi, Guncheol Kim, Nakjeong Kim, 2005 .

In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.

H. Seo, S. Yoo, H. Shin, 1999, Journal of cardiovascular pharmacology.

Metabolism of a new neuroprotective agent for ischemia-rep-erfusion damage, KR-31543 in the rats using liquid chroma-tography/electrospray mass spectrometry

S. Yoo, S. O. Kim, H. Lee, 2002, Archives of pharmacal research.

Dose-dependent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378, in rats.

H. Kim, S. Yoo, S. H. Kim, 2000, Biopharmaceutics & drug disposition.

Reversal of multidrug resistance by novel verapamil analogs in cancer cells

S. Yoo, Sang-Un Choi, Hwa-Sup Shin, 1998, Anti-Cancer Drugs.

Subacute toxicity evaluation of KR-33493, FAF1 inhibitor for a new anti-parkinson's disease agent, after oral administration in rats and dogs.

Eunhee Kim, S. Yoo, Jong-Hwa Lee, 2016, Regulatory toxicology and pharmacology : RTP.

Comparative molecular field analysis (CoMFA) for phosphodiesterase (PDE) IV inhibitors

N. Kang, S. Yoo, C. Chae, 2007 .

Letter: Acetyl transfer reaction in catechol acetate malonate. A model for the biosynthesis of polyketides and fatty acids.

A. Scott, S. Yoo, S. K. Chung, 1975, Journal of the American Chemical Society.

Computational studies of COX-2 inhibitors: 3D-QSAR and docking.

Chong Hak Chae, Sung-Eun Yoo, Kyung-Lae Park, 2004, Bioorganic & medicinal chemistry.

Design and synthesis of fluorescent and biotin tagged probes for the study of molecular actions of FAF1 inhibitor.

N. Kang, Eunhee Kim, S. Yoo, 2016, Bioorganic & medicinal chemistry letters.

K. Hong, Ki Young Kim, S. Chae, 2002 .

HPLC ANALYSIS OF A NEW NEUROPROTECTIVE AGENT FOR ISCHEMIA-REPERFUSION DAMAGE, A BENZOPYRAN DERIVATIVE, IN PLASMA AND URINE

E. J. Kim, S. Yoo, Myung G. Lee, 2002 .

Daxx is a key downstream component of receptor interacting protein kinase 3 mediating retinal ischemic cell death

Yun S. Lee, Eunhee Kim, S. Yoo, 2013, FEBS letters.